On one hand, in a mouse model of breast cancer, docetaxel‐conjugated nanoparticles targeting α‐SMA‐expressing stromal cells effectively inhibited metastasis, demonstrating potential therapeutic efficacy [484]. Here, ACTA1 is linked to breast carcinoma.